💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Lifevantage Corporation (LXRX)
« Back to company indexLXRX Chatter Timeline
Stock Ticker for LXRX
Most Active Tweeters for LXRX
| User | Tweets |
|---|---|
| @Tickeron | 7 |
| @PennySearch | 3 |
| @invescent | 2 |
| @Serge29948835 | 2 |
| @Tikenw1Tikenw | 1 |
Recent Tweets for LXRX
 |
@ChartMill $LXRX shows a strong growth in EPS: 53.85%. https://t.co/dn3sJsH66A https://t.co/jzFjT3E9ic January 25th 2022, 10:01pm |
 |
@ShortAlgoTrades $LXRX Look at this! Profit Factor of 9 and trade profitability of 88.89%9 trades executed and buy signal in place… https://t.co/OA4JYC9IHl January 25th 2022, 9:01am |
 |
@Tickeron $LXRX in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on January 5, 2022. View odds for th… https://t.co/uc4jYw9sn4 January 24th 2022, 9:01pm |
 |
@Tikenw1Tikenw The average discretionary accruals of $LXRX in recent quarters is large, which is higher than 85% of other firms in… https://t.co/c16DTZP0I5 January 23rd 2022, 7:01am |
 |
@DanGamesPoker RT @DansGamePoker: Taking it easy locking up my small wins like this 3k shares of $LXRX in at 2.57, out at 2.77. It kept going which is fi… January 22nd 2022, 5:01pm |
 |
@PennySearch $LXRX Wedbush gave LXRX a Neutral stock rating on 2021-01-29. Find top penny stocks with PennySearch before the… https://t.co/AxiaKPrxU6 January 22nd 2022, 2:01am |
|
@Info53681772 @TraderOfStocks1 what a BS... this article hasn't anything about $lxrx... your account is reported. January 21st 2022, 2:01pm |
|
@Tickeron $LXRX in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on January 5, 2022. View odds for th… https://t.co/Dx9DRNkH0p January 21st 2022, 12:01am |
|
@Tickeron This is why Hedge Funds use A.I. $LXRX RSI Indicator left the oversold zone. #LexiconPharmaceuticals #stockmarket… https://t.co/YODAEiAHlU January 20th 2022, 2:01am |
|
@PennySearch $LXRX Wedbush gave LXRX a Neutral stock rating on 2021-01-29. Find top penny stocks with PennySearch before the… https://t.co/sgz3qyRoeY January 18th 2022, 2:01pm |
 |
@ironicpoor RT @Tickeron: $LXRX's Aroon indicator drops into Downtrend on December 30, 2021. View odds for this and other indicators: https://t.co/ntNu… January 18th 2022, 1:01am |
|
@Tickeron $LXRX's Aroon indicator drops into Downtrend on December 30, 2021. View odds for this and other indicators:… https://t.co/8NVevUB9Bg January 18th 2022, 1:01am |
 |
@invescent $LXRX Data indicates that the overall analyst sentiment for LXRX is bearish. Simplify the way you research stock… https://t.co/0NgZYiqeR2 January 17th 2022, 11:01pm |
|
@PennySearch $LXRX Wedbush gave LXRX a Neutral stock rating on 2021-01-29. Find top penny stocks with PennySearch before the… https://t.co/FocECJT1Ju January 17th 2022, 1:01pm |
|
@Tickeron $LXRX's Aroon indicator drops into Downtrend on December 30, 2021. View odds for this and other indicators:… https://t.co/J0A5aqNPTZ January 14th 2022, 1:01pm |
|
@Tickeron How will this affect the market? $LXRX RSI Indicator left the oversold zone. #LexiconPharmaceuticals #stockmarket… https://t.co/Zp2I5I9NBa January 14th 2022, 6:01am |
 |
@Serge29948835 $lxrx The biggest concern for me will be if the company will be able to start producing and manufacturing the drug… https://t.co/AgrpvnthuQ January 13th 2022, 10:01pm |
|
@Serge29948835 $lxrx I love to see the pieces all falling into place . Like I’ve said I am expecting the Fda will approve the drug… https://t.co/7RkJeY7nR8 January 13th 2022, 10:01pm |
|
@invescent $LXRX Data indicates that the overall analyst sentiment for LXRX is bearish. Simplify the way you research stock… https://t.co/TMHkWbKv6o January 13th 2022, 7:01pm |
 |
@MarketCurrents $LXRX - Lexicon Pharmaceuticals expects potential launch of heart drug in H2 https://t.co/dAY09sLrDv January 13th 2022, 4:01pm |
 |
@Briefingcom $LXRX: Lexicon Pharma outlines potential value drivers for 2022 at 40th Annual J.P. Morgan Healthcare Conference https://t.co/FRNCHWP4vq January 13th 2022, 4:01pm |
 |
@MarcJacksonLA $LXRX Lexicon Pharmaceuticals Outlines Major Potential Value Drivers for 2022 at 40th Annual J.P. Morgan Healthcare… https://t.co/L8NiiVzDB1 January 13th 2022, 3:01pm |
 |
@FlashAlert_me $LXRX [15s. delayed]: Issued Press Release on January 13, 09:00:00: Lexicon Pharmaceuticals Outlines Major Potentia… https://t.co/jog6ZlV2Rv January 13th 2022, 2:01pm |
 |
@StockNewsBot2 $LXRX Lexicon Pharmaceuticals Outlines Major Potential Value Drivers for 2022 at 40th Annual J.P. Morgan Healthcare… https://t.co/lAzKuY2OUO January 13th 2022, 2:01pm |
 |
@stock_titan $LXRX Lexicon Pharmaceuticals Outlines Major Potential Value Drivers for 2022 at 40th Annual J.P. Morgan Healthcare… https://t.co/HPDwE95Oct January 13th 2022, 2:01pm |
|
@Tickeron $LXRX in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on January 5, 2022. View odds for th… https://t.co/rwLp2k9I22 January 12th 2022, 6:01pm |
|
@PennySearch $LXRX Wedbush gave LXRX a Neutral stock rating on 2021-01-29. Find top penny stocks with PennySearch before the… https://t.co/zuiRTjmB1P January 11th 2022, 10:01pm |
|
@Tickeron This is why Hedge Funds use A.I. $LXRX RSI Indicator left the oversold zone. #LexiconPharmaceuticals #stockmarket… https://t.co/Uh55KewVFK January 11th 2022, 10:01pm |
 |
@InsiderAlerts4U $LXRX: New Insider Filing on LEXICON PHARMACEUTICALS, INC.'s VP, Human Resources WENDY MCDERMOTT: https://t.co/2cZTC1Z22f January 11th 2022, 4:01pm |
|
@InsiderAlerts4U $LXRX: New Insider Filing on LEXICON PHARMACEUTICALS, INC.'s Director CHRISTOPHER J SOBECKI: https://t.co/AOeyzzlcZQ January 11th 2022, 4:01am |
|
@Tickeron $LXRX in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on January 5, 2022. View odds for th… https://t.co/IrGpAhqvHw January 9th 2022, 7:01pm |
|
@Tickeron $LXRX in Downtrend: 50-day Moving Average broke below 200-day Moving Average on January 5, 2022. View odds for this… https://t.co/tewi6f095s January 8th 2022, 9:01pm |
 |
@1stOncology #LexiconPharmaceuticals to Participate in the 40th Annual J.P. Morgan #HealthcareConference $LXRX https://t.co/WLWhYuxPp2 January 6th 2022, 10:01am |
 |
@PenkeTrading I found you a Death Cross on the daily chart of Lexicon Pharmaceuticals Inc. $LXRX $LXRX.NASDAQ #deathcross… https://t.co/YXoqH0ZMow January 6th 2022, 9:01am |
|
@PennySearch $LXRX Wedbush gave LXRX a Neutral stock rating on 2021-01-29. Find top penny stocks with PennySearch before the… https://t.co/TYXx2g47fz January 5th 2022, 11:01pm |
|
@Tickeron Does this make you nervous? $LXRX Stochastic Oscillator left the oversold zone. #LexiconPharmaceuticals… https://t.co/KFmaxROLMK January 5th 2022, 7:01pm |
|
@Tickeron This is amazing! What do you think? $LXRX entered a Downtrend because Momentum Indicator dropped below the 0 level.… https://t.co/6Qt9qqztJc January 5th 2022, 7:01pm |
|
@PennySearch $LXRX Wedbush gave LXRX a Neutral stock rating on 2021-01-29. Find top penny stocks with PennySearch before the… https://t.co/VFzScp9qaG January 5th 2022, 12:01pm |
|
@FlashAlert_me $LXRX [15s. delayed] filed SEC form 4: Insider McDermott Wendy: Transacted Derivative Securities on 2022-01-03. https://t.co/TWSqy8Hpik January 5th 2022, 4:01am |
 |
@newsfilterio Lexicon Pharmaceuticals to Participate in The 40th Annual J.P. Morgan Healthcare Conference $LXRX https://t.co/GpgsFn0liQ January 5th 2022, 1:01am |
|
@FlashAlert_me $LXRX [15s. delayed] filed SEC form 3: Insider McDermott Wendy: https://t.co/vOd091ejRv January 5th 2022, 12:01am |
|
@newsfilterio Form 3 (initial statement of beneficial ownership of securities) filed with the SEC $LXRX https://t.co/WDt7qV9FgM January 5th 2022, 12:01am |
 |
@TheTradaXchange RT @TheTradeXchange: $LXRX: Lexicon Submits New Drug Application for Sotagliflozin for the Treatment of Heart Failure in Adults With Type 2… January 4th 2022, 11:01pm |
 |
@TradeWithAlerts Nice print for $LXRX Size: 223000 Price: 3.84 Amount: $856,320.00 Time: 1728 See more: https://t.co/5xvY1yyiDu Join… https://t.co/OTHASM1dEb January 4th 2022, 10:01pm |
|
@FlashAlert_me $LXRX [15s. delayed]: Issued Press Release on January 04, 16:05:00: Lexicon Pharmaceuticals to Participate in The 4… https://t.co/99mrwlFrxz January 4th 2022, 9:01pm |
|
@StockNewsBot2 $LXRX Lexicon Pharmaceuticals to Participate in The 40th Annual J.P. Morgan Healthcare Conference https://t.co/uTaiCHWpMa January 4th 2022, 9:01pm |
|
@stock_titan $LXRX Lexicon Pharmaceuticals to Participate in The 40th Annual J.P. Morgan Healthcare Conference https://t.co/TeTz7IVg4Q January 4th 2022, 9:01pm |
 |
@Ba4Saso $LXRX Awaiting Buy Signal. Chart by https://t.co/z6vAd7dl0q https://t.co/4tvsoL9BPV January 4th 2022, 3:01pm |
|
@Tickeron $LXRX's Aroon indicator drops into Downtrend on December 30, 2021. View odds for this and other indicators:… https://t.co/YoLxuUtLez January 4th 2022, 11:01am |
|
@PennySearch $LXRX Wedbush gave LXRX a Neutral stock rating on 2021-01-29. Find top penny stocks with PennySearch before the… https://t.co/UfUnA12j8E January 4th 2022, 1:01am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?